Why the study?
Heart failure is a heterogeneous disease with multiple risk factors and pathophysiological types, making it difficult to understand its underlying molecular mechanisms.
A trans-omics approach identified Nppa as a key marker gene associated with specific transcriptional and metabolic changes during the early stages of cardiac hypertrophy.
Nppa marks early mitochondrial changes in hypertrophic cardiomyocytes; hypothesis-generating for mechanisms but leaves open human HF relevance.
Heart failure is a heterogeneous disease with multiple risk factors and various pathophysiological types, which makes it difficult to understand the molecular mechanisms involved. In this study, we proposed a trans-omics approach for predicting molecular pathological mechanisms of heart failure and identifying marker genes to distinguish heterogeneous phenotypes, by integrating multiple omics data including single-cell RNA-seq, ChIP-seq, and gene interactome data. We detected a significant increase in the expression level of natriuretic peptide A (Nppa), after stress loading with transverse aortic constriction (TAC), and showed that cardiomyocytes with high Nppa expression displayed specific gene expression patterns. Multiple NADH ubiquinone complex family, which are associated with the mitochondrial electron transport system, were negatively correlated with Nppa expression during the early stages of cardiac hypertrophy. Large-scale ChIP-seq data analysis showed that Nkx2-5 and Gtf2b were transcription factors characteristic of high-Nppa-expressing cardiomyocytes. Nppa expression levels may, therefore, represent a useful diagnostic marker for heart failure.
No takes yet. Share an insight, caveat, or question.
Hamano et al. (2021) studied Heart failure. Transverse aortic constriction (TAC) vs. Sham operation was evaluated on Gene expression changes (Nppa).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: